Itching to end NF-kB.

Abstract

Both activation and termination of transcription factor NF-kB signaling require ubiquitin modification of pathway components. The E3 ligase Itch teams up with the NF-kB inhibitor A20 to edit the composition of ubiquitin chains on the signaling adaptor RIP, thereby limiting inflammatory responses